[1]Bober samek P.Surgery of tumours of liver[J].Bratisl Lek Listy, 2002, 103∶403-407.
|
[2] 陈孝平.原发性肝癌外科治疗方法的选择[J].中华肝脏病杂志, 2001, 9 (3) ∶134-136.
|
[3] 中华外科学分会肝脏外科学组.原发性肝癌外科治疗方法的选择[J].中华外科杂志, 2001, 39 (1) ∶762-763.
|
[4]陈孝平、吴在德、裘法祖.我国原发性肝癌外科治疗的历史回顾、现状与展望[J].中国普外基础与临床杂志, 2000, 7∶257-258.
|
[5]汤钊猷.肝癌研究进展[J].中国肿瘤, 2001, 10 (1) ∶37-40.
|
[6] 吴孟超, 陈汉, 沈锋.原发性肝癌的外科治疗[J].中华外科杂志, 2001, 39 (1) ∶25.
|
[7]周信达.肝癌的论断治疗:20世纪的进展与21世纪的研究重点[J].中国实用外科杂志, 2000, 20 (1) ∶26.
|
[8]郭伟剑, 孙磊, 宋明志, 等.肝动脉结扎加插化疗结合外放射治疗25例肝癌[J].浙江肿瘤, 1999, 5 (2) ∶77.
|
[9]Laiecs JH, Locm T, Fanst W, et al.Postoperative adjuvant chemo-therapy after 2curtice resection of hepatocellular carcinoma:a ran-domized controlled trail[J].Arch Surg, 1998, 133 (2) ∶183-188.
|
[10]何生, 薛华.原发性肝癌治疗现状与评价[J].肝胆外科杂志, 2000, 8 (2) ∶162-164.
|
[11]Fan J, Tang ZY, Yuyq W, et al.Improved snrvival with resectinafter transcathcter arterial chemoembokization for unresectable hepa-tocellular carcinoma[J].Dig-surg, 1998, 15 (2) ∶674-678.
|
[12]吴孟超.原发性肝癌治疗的进展及展望[J].第二军医大学学报, 2002, 23 (1) ∶1-4.
|
[13]胡大武, 陈君辉, 伍海翔.肝动脉化疗栓塞结合经皮肝穿刺瘤内注射醋酸治疗原发性肝癌坏死因子的变化[J].肝胆外科杂志, 2004, 13 (1) ∶53-55.
|
[14]鲍因武, 马庆久, 赖大年, 等.射频治疗原发性肝癌前后可溶性折细胞介素-2受体和肿瘤坏死因子的变化[J].肝胆外科杂志, 2003, 11 (4) ∶278-279.
|
[15]管军, 姚晓平, 吴孟超.微波组织凝固诱导荷瘤宿主的抗肿瘤效应[J].中华物理医学与健康杂志, 1999, 21 (4) ∶97-99.
|
[16]葛益谋, 世元, 黄华世.原发性肝癌超低温超导系统氩氦刀治疗前后血清可溶性E-cadherin水平的变化[J].广西医科大学学报, 2000, 17 (16) ∶1045-1046.
|
[17]Kanaif A, Lankh K, Shiratorc Y, et al.Invivo gene therapy for al-pha 2fetoproteiupro 2ducing hepatocellular cancinoma by aden2ovirus 2 mediated transfer of cytosine deami 2nase gene[J].CancerRes, 1997, 57 (4) ∶461-465.
|
[18]Barajasm W, Mazzolinig T, Genoveg B, et al.Gene therapy of or-thotopic hepatocellu 2lar carinoma in rats uxing adenovirus codingrforinterlcukin 212[J].Hepatology, 2001, 33 (1) ∶52-61.
|